最近,在美国纽约举行了白细胞粘附抑制(LAI)试验专题讨论会。会上采用双盲“编码”标本,用多种方法对两个肿瘤抗原进行十字交叉反应,获得了成功。讨论会还涉及LAI临床研究,试验的抗原和机制的探讨,使一度低落的LAI在临床及基础研究上又取得了某些进展。木文就近几年来LAI试验的一些进展情况作一介绍。 Recently, a symposium on leukocyte adhesion inhibition (LAI) test was held in New York, USA. At the meeting, double-blind “coding” specimens were used to cross-react with two tumor antigens in a variety of ways and achieved success. The discussion also involved LAI clinical studies, the exploration of antigens and mechanisms, and the progress of LAI, which had been declining, in clinical and basic research. Mu Wen made some introductions to the progress of the LAI test in recent years.